Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05052242
Other study ID # Rajavithi hospital
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2020
Est. completion date September 3, 2021

Study information

Verified date September 2021
Source Rajavithi Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose: To investigate agreement between 2 swept source OCT biometers, IOL M.aster700 and Anterion, in various ocular biometry and intraocular lens (IOL) calculations of primary angle-closure disease (PACD). Methods: This was a prospective study conducted in a tertiary eye care centre involving biometric measurements obtained with 2 devices in phakic eye with diagnosis of PACD. Mean difference and intraclass correlation coefficient (ICC) with confidence limits were assessed, and calculations of estimated residual refraction of the IOL were analysed using Barrett's formula.


Description:

Primary angle-closure disease (PACD) is the leading cause of blindness worldwide. PACD is an anatomic disorder, typically of relatively small eye with shallow anterior chamber depth (ACD), thick lens, shorter axial length (AL), small corneal curvature, and relatively anterior lens position. Pupillary block, plateau iris and phacomorphic mechanisms play major roles in the pathophysiology of the disease, and pupillary block is thought to be the most common causal mechanism. For decades, phacoemulsification and intraocular lens implantation (PEI) has been proposed for initial management of PACD.4 PEI relieves pupillary block, deepening ACD and widening irido-corneal angle. Biometry is essential in evaluating ocular dimensions and calculating IOL power in PACD, and ocular biometers have been evolving in recent years. Optical coherence tomography (OCT) includes partial coherence interferometry (PCI), and swept source OCT (SS-OCT) is in general use in clinical practice. The agreement of the calculations of these devices has been studied by many investigators; however, research into their agreement in PACD patients has been sparse so far. A newer SS-OCT, Anterion, is now available and its performance needs to be evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date September 3, 2021
Est. primary completion date August 31, 2021
Accepts healthy volunteers
Gender All
Age group 40 Years to 77 Years
Eligibility Inclusion Criteria: - Inclusion criteria were age > 40 years old - phakic eye - diagnosis of PACD, including primary angle-closure suspect (PACS), primary angle-closure (PAC) and primary angle-closure glaucoma (PACG) as classified by Foster et al Exclusion Criteria: - patients who had opaque optical media - dense cataract - anterior and/or posterior segment diseases such as advanced pterygium, diabetic retinopathy, or maculopathy - Participants who had previous history of ocular trauma, ocular surgery

Study Design


Intervention

Diagnostic Test:
primary angle closure disease
2 swept source OCT biometers, IOL Master700 and Anterion

Locations

Country Name City State
Thailand Somporn Chantra Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Rajavithi Hospital

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intraclass correlation coefficient of IOL power calculation agreement between 2 swept source OCT biometers, IOL Master700 and Anterion, in intraocular lens (IOL) calculations 30 minutes per person
Primary Intraclass correlation coefficient of various ocular biometry agreement between 2 swept source OCT biometers, IOL Master700 and Anterion, in various ocular biometry( ACD, AL, LT, K1, K2, WTW) 30 minutes per person
See also
  Status Clinical Trial Phase
Recruiting NCT02279472 - Optical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral Lridotomy N/A
Recruiting NCT04736264 - Malay Glaucoma Eye Study II Navigation, Mobility and Reading Ability in Primary Glaucoma N/A
Completed NCT06252246 - The Effect of Phacoemulsification on Intraocular Pressure in Primary Angle Closure Glaucoma (PACG) Patients At Phanat Nikhom Hospital, Chonburi Province
Completed NCT04622605 - Hydrus Microstent and Lens Extraction for the Treatment of Primary Angle-Closure Glaucoma N/A
Recruiting NCT05163951 - Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG N/A
Completed NCT04972435 - Effect of Multifocal Intraocular Lens on Contrast Sensitivity in Primary Angle-Closure Patients N/A
Completed NCT06184620 - Correlation Between Angle Closure Glaucoma Data and Lens Zonule Status
Terminated NCT01301378 - Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube N/A